Gauri R. Varadhachary

Author

The University of Texas MD Anderson Cancer Center

Also Known As

G Varadhachary, G. R. Varadhachary, G. Varadhachary, G.R. Varadhachary, Gauri R Varadhachary, Gauri R. Varadhachary, Gauri Rajani Varadhachary, Gauri Varadhachary, Hua Wang, Jason B. Fleming

365

Publications

15.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Baylor College of Medicine Medical College of Wisconsin

About

Gauri R. Varadhachary is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	64	5.3K
2	Health Sciences	12	12	893
3	Engineering	1	1	19
4	Humanities	1	1	34
5	Biostatistics	1	1	19

Gauri R. Varadhachary

129

Publications

13.2K

Citations

H-Index

Page 1

	Year	Citations
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans, Journal of the American College of Surgeons	2008	813
Metastatic patterns in adenocarcinoma Kenneth R. Hess, Gauri R. Varadhachary, Sarah Taylor, Cancer	2006	813
Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head Douglas B. Evans, Gauri R. Varadhachary, Christopher H. Crane, Journal of Clinical Oncology	2008	726
High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients Kelvin Allenson, J.J. Soto Castillo, F Anthony San Lucas, Annals of Oncology Pancreatic CancerMedicineExosome-derived DnaPathologyHigh Prevalence	2017	471
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane, Journal of Clinical Oncology	2008	466
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Rachna T. Shroff, Milind Javle, Lianchun Xiao, JAMA Oncology	2019	460
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation Sunil Krishnan, Awalpreet S. Chadha, Yelin Suh, International Journal of Radiation OncologyBiologyPhysics Radiation MedicinePancreatic CancerRadiation TherapyOverall SurvivalMedicine	2015	359
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer Vincent Bernard, Dong U. Kim, F. Anthony San Lucas, Gastroenterology Pancreatic CancerGastrointestinal OncologyMedicinePathologyCancer Genomics	2018	354
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer Jorge Blando, Anu Sharma, Maria G. Higa, Proceedings of the National Academy of Sciences	2019	317
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary, The Lancet Oncology Phase 1BPancreatic CancerMetastatic Pancreatic AdenocarcinomaMedicineImmunology	2020	286

Page 1